We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Generic Firms Position For Launch of First Lovenox Equivalent
Generic Firms Position For Launch of First Lovenox Equivalent
August 26, 2005
Competition to launch the first generic version of sanofi-aventis’ profitable blood thinner Lovenox has heated up after Momenta Pharmaceuticals said it was able to duplicate biologic drugs by characterizing complex sugars.